Cart is empty
View Cart
Subtotal: $0.00
JOIN NOW!
  • ABOUT US
    • Board of Directors
    • Benefits
    • Volunteering
      • Volunteer Opportunities
      • Communications
      • EDEI Committee
      • Education
      • Emerging Leaders
      • Membership
      • Product Show
      • Social
      • Student Development
      • Women in Pharma®
    • Students
      • Student Chapters
      • Career Workshop
      • Poster Contest
      • Scholarships
    • Chapter Awards
    • Sponsors
    • Contact Us
  • EVENTS
    • Chapter Calendar
    • Educational Programs
    • Social Events
    • Student Activities
    • Product Show
    • Past Events
  • RESOURCES
    • Scholarship Foundation
      • Scholarship Application
    • Podcast
    • Documents
    • Chapter YouTube Channel
    • ISPE Publications
    • ISPE Guidance Documents
    • Member Directory
    • ISPE Training
    • ISPE Communities of Practice
  • BLOG
    • Boston Chapter Blog
      • Contribute
    • ISPE Blog
  • CAREERS
    • Job Board
    • Post a Job
  • Gallery
  • SCHOLARSHIP FOUNDATION
    • About the Foundation
    • Apply for a Scholarship
    • Donate
  • ABOUT US
    • Board of Directors
    • Benefits
    • Volunteering
      • Volunteer Opportunities
      • Communications
      • EDEI Committee
      • Education
      • Emerging Leaders
      • Membership
      • Product Show
      • Social
      • Student Development
      • Women in Pharma®
    • Students
      • Student Chapters
      • Career Workshop
      • Poster Contest
      • Scholarships
    • Chapter Awards
    • Sponsors
    • Contact Us
  • EVENTS
    • Chapter Calendar
    • Educational Programs
    • Social Events
    • Student Activities
    • Product Show
    • Past Events
  • RESOURCES
    • Scholarship Foundation
      • Scholarship Application
    • Podcast
    • Documents
    • Chapter YouTube Channel
    • ISPE Publications
    • ISPE Guidance Documents
    • Member Directory
    • ISPE Training
    • ISPE Communities of Practice
  • BLOG
    • Boston Chapter Blog
      • Contribute
    • ISPE Blog
  • CAREERS
    • Job Board
    • Post a Job
  • Gallery
  • SCHOLARSHIP FOUNDATION
    • About the Foundation
    • Apply for a Scholarship
    • Donate

Amgen’s Humira Biosimilar Moves Forward in Europe Amid Patent Fight with Abbvie

  • Posted by jwillard
  • On February 6, 2017

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for the Marketing of ABP 501, a biosimilar for Abbvie’s Humira (adalimumab). The committee recommended approval for all available indications, including moderate-to-severe rheumatoid arthritis, chronic plaque psoriasis, Crohn’s disease and ulcerative colitis.

ABP 501 is the first Humira biosimilar recommended for EMA Approval. In September 2016, ABP 501 won FDA approval in the US, where it goes by the brand name AMJEVITA™ (adalimumab-atto). AMJEVITA is currently not available commercially, though, amid ongoing patent litigation in the U.S. Humira is Abbvie’s biggest seller, accounting for approximately $4 billion of AbbVie’s $6.7 billion earnings last quarter.

The CHMP positive opinion will now be reviewed by the European Commission (EC), which has the authority to approve medicines for the European Union (EU). If approved, a centralized marketing authorization will be granted that will be valid in the 28 countries that are members of the EU. (Source: Amgen.com and news.abbvie.com)

Share on Facebook Share
Share on TwitterTweet
Share on LinkedIn Share
Send email Mail
Print Print
 
Post Categories
  • Industry Buzz (466)
  • Chapter News (433)
  • Knowledge & Training (73)
  • Students & YP (69)
  • Career Tools (11)
Get Updates via Email




Support our Sponsors

Takeda to Acquire ARIAD Pharmaceuticals

Ping Pong, Baseball and Networking: A Great Start to 2017

Next thumb
Scroll
Follow Us
Search this Site
@2021 ISPE Boston Chapter. All rights reserved.